9068 Results

Journal Article

Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer

Authors: Jelena Lukovic, Ali Hosni, Amy Liu, Jasmine Chen, Tony Tadic, Tirth Patel, Kecheng Li, Kathy Han, Patricia Lindsay, Tim Craig, James Brierley, Aisling Barry, Rebecca Wong, Jolie Ringash, Laura A. Dawson, John J. Kim

Journal Article

Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation

Authors: Xiangrong Sharon Qi, Frank Pajonk, Susan McCloskey, Daniel A. Low, Patrick Kupelian, Michael Steinberg, Ke Sheng

Journal Article

A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer

Authors: Ann-Charlotte Waldenström, Karin Bergmark, Annika Michanek, Farida Hashimi, Rauni Rossi Norrlund, Caroline E. Olsson, Peter Gjertsson, Henrik Leonhardt

Journal Article

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy

Authors: Jay S. Detsky, Laurent Milot, Yoo-Joung Ko, Pablo Munoz-Schuffenegger, William Chu, Gregory Czarnota, Hans T. Chung

Journal Article

Cardiac and respiration induced motion of mediastinal lymph node targets in lung cancer patients throughout the radiotherapy treatment course

Authors: Mai Lykkegaard Schmidt, Lone Hoffmann, Marianne Marquard Knap, Torben Riis Rasmussen, Birgitte Holst Folkersen, Jakob Toftegaard, Ditte Sloth Møller, Per Rugård Poulsen

Congress Abstract

An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT

Authors:

Alessandro Cicchetti1, Nuradh Joseph2, Petra Seibold3, Barbara Avuzzi4, Riccardo Valdagni5, Adam Webb6, Dirk De Ruysscher7, Maarten Lambrecht8, Elena Sperk9, Rebecca Elliott10, Christopher Talbot11, Liv Veldeman12, Jenny Chang-Claude3, Ananya Choudhury13, Ana Vega14, David Azria15, Tiziana Rancati16, Catharine West17

1Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Prostate Cancer Program, Milan, Italy; 2General Hospital Chilaw, Ministry of Health, Chilaw, Sri Lanka; 3German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany; 4Fondazione IRCCS Istituto Tumori di Milano, Radiation Oncology 1, Milan, Italy; 5University of Milan, Department oncology and hematoncology, Milan, Italy; 6University of Leicester, Department of Genetics and Genome Biology, Leicester, United Kingdom; 7Maastricht University Medical Center, Department of Radiation Oncology, Maastricht, Belgium; 8University Hospitals Leuven, -, Leuven, Belgium; 9University of Heidelberg, Department of Radiation Oncology, Mannheim,, Germany; 10 University of Manchester, Translational Radiobiology Group, Division of Cancer Sciences, Manchester, United Kingdom; 11University of Leicester, Leicester Cancer Research Centre,, Leicester, United Kingdom; 12Ghent University, Department of Human Structure and Repai, Ghent, Belgium; 13University of Manchester, Christie Hospital, Division of Cancer Sciences Translational Radiobiology Group, Manchester, United Kingdom; 14Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; 15Montpellier Cancer Institute, Department of Radiation Oncology, Montpellier, France; 16Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, milan, Italy; 17 University of Manchester, Manchester Academic Health Science Centre,, Translational Radiobiology Group, Division of Cancer Sciences,, Manchester, United Kingdom

Show Affiliations

Congress Abstract

Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer

Authors: SPOHN|, Simon(1)*[Simon.Spohn@uniklinik-freiburg.de];Jaegle|, Chiara(2);Bettermann|, Alisa S.(2);Kiefer|, Selina(3);Jilg|, Cordula A.(4);Kranz-Rudolph|, Jasmin(2);Fassbender|, Thomas F.(5);Bronsert|, Peter(3);Nicolay|, Nils H.(2);Bock|, Michael(6);Ruf|, Juri(5);Benndorf|, Matthias(6);Grosu|, Anca L.(2);Zamboglou|, Constantinos(2);
(1)University Medical Centre Freiburg, Department of Radiation Oncology, Freiburg, Germany;(2)University Medical Center Freiburg, Department of Radiation Oncology, Freiburg, Germany;(3)University Medical Centre Freiburg, Institue for Surgical Pathology, Freiburg, Germany;(4)University Medical Centre Freiburg, Department of Urology, Freiburg, Germany;(5)University Medical Centre Freiburg, Department of Nuclear Medicine, Freiburg, Germany;(6)University Medical Centre Freiburg, Department of Radiology, Freiburg, Germany;
Show Affiliations

Congress Abstract

A predictive model for OS in patients treated with Stereotactic Radiotherapy for early-stage NSCLC

Authors:

Paolo Borghetti1, Gianluca Costantino1, Valeria Santoro2, Matteo Sepulcri3, Marta Maddalo1, Diana Greco1, Francesco Frassine1, Paola Vitali1, Edoardo Pastorello1, Salvatore La Mattina1, Giulia Volpi1, Jessica Imbrescia1, Stefano Maria Magrini1

1ASST Spedali Civili and University of Brescia, Radiation Oncology, Brescia, Italy; 2Istituto Oncologico Veneto IRCCS, Radiation Oncology, Padova, Italy; 3Istituto Oncologico Veneto IRCCS , Radiation Oncology, Padova, Italy

Show Affiliations

Webcast

Update on the ARCON study

Authors: W. Bots, C. Terhaard, M. Vergeer, P. Doornaert, H. Bijl, P. van den Ende, M. de Jong, G. Janssens, P. Span Johannes Kaanders

Congress Abstract

Anatomical changes in prostate SBRT: dosimetric effects and CTV to PTV margins verification

Authors:

Ines Flores-Cacho1, Alejandro Prado Barragán2, Miguel Ángel De la Casa2, Daniel Collado Álvarez2, Carmen Gómez Agudo2, Ruth Martín Álvarez2, Ángel Montero Luis3, Pedro Fernández Letón2

1Hospital Central de la Defensa "Gómez Ulla", Servicio de Protección Radiológica y Radiofísica, Madrid, Spain; 2Hospital Universitario HM Sanchinarro, Radiofísica, Madrid, Spain; 3Hospital Universitario HM Sanchinarro, Oncología Radioterápica, Madrid, Spain

Show Affiliations
*:*